The American Society of Clinical Oncology (Asco) Net Health Benefit (Nhb) Assessment Tool- Which Implications for Value Assessment of Cancer Therapies?
Abstract
Authors
C Rémuzat C Chouaid P Auquier I Borget M Kornfeld M Toumi
C Rémuzat C Chouaid P Auquier I Borget M Kornfeld M Toumi
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now